That's an excellent summary, and it only hints at potential future valuations, but it's impact is a little reduced by the fact that SHC pays for the coverage
Excitement Among Proof-of-Concept Drug Companies Could Spill Over Into This Lesser-Known Name, page-2
Add to My Watchlist
What is My Watchlist?